Valneva Se Stock Fundamentals
| INRLF Stock | USD 4.52 0.25 5.24% |
Fundamental analysis of Valneva SE allows traders to better anticipate movements in Valneva SE's stock price by examining its financial health and performance throughout various phases of its business cycle.
Valneva |
Valneva SE Company Profit Margin Analysis
Valneva SE's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Valneva SE Profit Margin | 0.17 % |
Most of Valneva SE's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valneva SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Valneva SE has a Profit Margin of 0.1674%. This is 101.49% lower than that of the Healthcare sector and 100.73% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 113.18% lower than that of the firm.
Valneva SE Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Valneva SE's current stock value. Our valuation model uses many indicators to compare Valneva SE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Valneva SE competition to find correlations between indicators driving Valneva SE's intrinsic value. More Info.Valneva SE is rated below average in return on equity category among its peers. It is rated third overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Valneva SE's earnings, one of the primary drivers of an investment's value.Valneva Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valneva SE's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Valneva SE could also be used in its relative valuation, which is a method of valuing Valneva SE by comparing valuation metrics of similar companies.Valneva SE is currently under evaluation in profit margin category among its peers.
Valneva Fundamentals
| Return On Equity | -1.86 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 880.26 M | |||
| Shares Outstanding | 138.22 M | |||
| Shares Owned By Insiders | 17.56 % | |||
| Shares Owned By Institutions | 21.62 % | |||
| Price To Earning | (4.57) X | |||
| Price To Book | 5.63 X | |||
| Price To Sales | 2.23 X | |||
| Revenue | 348.08 M | |||
| Gross Profit | (13.12 M) | |||
| EBITDA | (38.73 M) | |||
| Net Income | (73.42 M) | |||
| Cash And Equivalents | 336.22 M | |||
| Cash Per Share | 2.87 X | |||
| Total Debt | 50.73 M | |||
| Debt To Equity | 1.43 % | |||
| Current Ratio | 1.15 X | |||
| Book Value Per Share | 1.56 X | |||
| Cash Flow From Operations | 76.9 M | |||
| Earnings Per Share | 0.90 X | |||
| Number Of Employees | 762 | |||
| Beta | 0.99 | |||
| Market Capitalization | 944.39 M | |||
| Total Asset | 817.35 M | |||
| Retained Earnings | (546.27 M) | |||
| Working Capital | 48.89 M | |||
| Current Asset | 89.75 M | |||
| Current Liabilities | 40.86 M | |||
| Z Score | 10.8 | |||
| Net Asset | 817.35 M |
About Valneva SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valneva SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| VOO | Vanguard SP 500 | |
| XLK | Technology Select Sector | |
| XLV | Health Care Select | |
| QQQ | Invesco QQQ Trust | |
| XLC | Communication Services Select |
Other Information on Investing in Valneva Pink Sheet
Valneva SE financial ratios help investors to determine whether Valneva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.